You are on page 1of 1

EFCORLIN Dosage & Drug Information | CIMS India

1 of 1

http://www.mims.com/India/drug/info/EFCORLIN/EFCORLIN nasal drops

Viewing: India | Change Region >>

Login / Register

Drugs

News & CME

Diagnoses
Search

Concise Info

Interaction Checker
Browse Drugs A-Z
Browse Companies
Browse CIMS Class

Advanced
Search
Usage

Latest News

Highlights

Highlights from the GW-ICC 2011


MIMS Pediatrics

Tips

Manufacturer Info

EFCORLIN - Concise Prescribing Information


> Manufacturer
> Contents

> CIMS Class


> ATC Classification
> Presentation/Packing

Browse Diagnoses
Browse Calculators
Related monographs
CIMS Publications
CIMS Integrated
Medical Events

See related EFCORLIN nasal drops information

Useful Links
Manufacturer

GSK

Contents

EFCORLIN nasal drops: hydrocortisone 0.02 %, naphazoline nitrate 0.025


%.
Click here to view naphazoline prescribing information, dosage, adverse drug
reactions...

CIMS Class

Nasal Decongestants & Other Nasal Preparations

ATC Classification R01AA08 - naphazoline ; Belongs to the class of topical sympathomimetic


agents used as nasal decongestants.
R01AB02 - naphazoline ; Belongs to the class of topical sympathomimetic
combination preparations, excluding corticosteroids. Used as nasal
decongestants.
S01GA01 - naphazoline ; Belongs to the class of sympathomimetics used as
ophthalmologic decongestants.

Prime Links

Featured Dr

Presentation/Packing
Form

Packing (Max Retail Price)

EFCORLIN nasal drops


Manufacturer:

Daksh Pharmaceutical Pvt.


Ltd.

10ml (20 INR)

AMARYL
B-PROTIN
CALCIROL
CERVARIX
ECOSPRIN
ESIFLO

GSK

Related EFCORLIN nasal drops information:


Drugs interacting with EFCORLIN
Find EFCORLIN in other countries

Ranbaxy Pharma

Search EFCORLIN in Google


Search EFCORLIN in PubMed

CIMS Abbreviation Index MIMS Abbreviation Index


Affordable Frontline
Diagnostic Products

Providing truly world class


healthcare solutions at
affordable p..

Browse cimsasia.com

Events

Asia-Pacific Resources

International Resources

Resource Centres

1/12/2012 1:14 PM

You might also like